Dr. Tarabar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1450 Chapel St
# Sasint
New Haven, CT 06511Phone+1 203-789-4044Fax+1 203-789-3007
Education & Training
Yale-New Haven Medical CenterResidency, Occupational and Environmental Medicine, 2001 - 2003- Yale-New Haven Medical CenterResidency, Internal Medicine, 1998 - 2001
OtherClass of 1994
Certifications & Licensure
CT State Medical License 2003 - 2020
Publications & Presentations
PubMed
- 6 citationsSafety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study.Srividya Neelakantan, Barry Oemar, Kristen Johnson, Natalie Rath, Mikhail Salganik
Clinical Pharmacology in Drug Development. 2021-03-01 - 44 citationsSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 Study.Arthur Bergman, Santos Carvajal-Gonzalez, Sanela Tarabar, Aditi R. Saxena, William P. Esler
Clinical Pharmacology in Drug Development. 2020-05-01 - 9 citationsPhase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent PopulationsSanela Tarabar, Debra Kelsh, Bradley Vince, Rina Leyva, Dongweon Song
Drugs in R&D. 2020-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
